Please assess the completion status of the following clinical trial:

Trial Title: Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes mellitus diagnosed by clinical/metabolic parameters and positive anti-GAD antibody~* Less than 6 months from diagnosis~Exclusion Criteria:~* Previous diabetic ketoacidosis~* Pregnancy~* Severe psychiatric disorder~* Severe organic impairment (renal, hepatic, cardiac, pulmonary)~* Active infectious disease~* Previous or present neoplastic disease

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- insulin therapy (Type: ACTIVE_COMPARATOR): The participants not accepted written informed consent will receive insulin therapy
- AHSCT (Type: EXPERIMENTAL): The participants accepted written informed consent will receive the therapy of autologous hematopoietic stem cell transplantation(AHSCT)

Based on this trial design, predict the completion outcome and termination type (if applicable).